Skip to content

Clinical trials

Terminated Carcinoma, Renal Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Terminated Country / region: South Korea Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20132
20151
20171
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Incyte Corporation1
Mirna Therapeutics, Inc.1
Pfizer1
SFJ Pharma Ltd. II1
Seoul National University Hospital1
Turnstone Biologics, Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell10
Melanoma5
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Bile Duct Neoplasms1
Cutaneous Squamous Cell Carcinoma1
Endometrial Neoplasms1
Esophageal Neoplasms1
Kidney Neoplasms1
Lymphoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.